These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 19818308)

  • 1. New imaging techniques for non-alcoholic steatohepatitis.
    Browning JD
    Clin Liver Dis; 2009 Nov; 13(4):607-19. PubMed ID: 19818308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-invasive diagnosis of steatosis and fibrosis.
    Castera L
    Diabetes Metab; 2008 Dec; 34(6 Pt 2):674-9. PubMed ID: 19195629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of radiologic modalities in the management of non-alcoholic steatohepatitis.
    Charatcharoenwitthaya P; Lindor KD
    Clin Liver Dis; 2007 Feb; 11(1):37-54, viii. PubMed ID: 17544971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance.
    Schwenzer NF; Springer F; Schraml C; Stefan N; Machann J; Schick F
    J Hepatol; 2009 Sep; 51(3):433-45. PubMed ID: 19604596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic criteria for non-alcoholic steatohepatitis].
    Hashimoto E
    Nihon Rinsho; 2006 Jun; 64(6):1025-32. PubMed ID: 16768105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions?
    Yilmaz Y
    Aliment Pharmacol Ther; 2012 Nov; 36(9):815-23. PubMed ID: 22966992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo imaging of hepatic fatty acid metabolism in patients with non-alcoholic steatohepatitis using semiquantitative 123I-labeled branched-chain fatty acid analog.
    Onishi S; Saibara T
    J Gastroenterol Hepatol; 2006 Oct; 21 Suppl 3():S76-8. PubMed ID: 16958679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive assessment of hepatic steatosis.
    Mazhar SM; Shiehmorteza M; Sirlin CB
    Clin Gastroenterol Hepatol; 2009 Feb; 7(2):135-40. PubMed ID: 19118644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive differentiation of simple steatosis and steatohepatitis by using gadoxetic acid-enhanced MR imaging in patients with nonalcoholic fatty liver disease: a proof-of-concept study.
    Bastati N; Feier D; Wibmer A; Traussnigg S; Balassy C; Tamandl D; Einspieler H; Wrba F; Trauner M; Herold C; Ba-Ssalamah A
    Radiology; 2014 Jun; 271(3):739-47. PubMed ID: 24576046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ultrasonography in the diagnosis of nonalcoholic fatty liver disease].
    Gomercić M; Duvnjak M; Barsić N
    Acta Med Croatica; 2009 Dec; 63 Suppl 3():1-3. PubMed ID: 20235368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic steatosis in obese Chinese children.
    Chan DF; Li AM; Chu WC; Chan MH; Wong EM; Liu EK; Chan IH; Yin J; Lam CW; Fok TF; Nelson EA
    Int J Obes Relat Metab Disord; 2004 Oct; 28(10):1257-63. PubMed ID: 15278103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging of hepatic steatosis and fatty sparing.
    Karcaaltincaba M; Akhan O
    Eur J Radiol; 2007 Jan; 61(1):33-43. PubMed ID: 17118603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of fatty liver disease: is biopsy necessary?
    Joy D; Thava VR; Scott BB
    Eur J Gastroenterol Hepatol; 2003 May; 15(5):539-43. PubMed ID: 12702913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and diagnosis of NAFLD/NASH.
    Hashimoto E; Taniai M; Tokushige K
    J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():64-70. PubMed ID: 24251707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years.
    Wong VW; Wong GL; Choi PC; Chan AW; Li MK; Chan HY; Chim AM; Yu J; Sung JJ; Chan HL
    Gut; 2010 Jul; 59(7):969-74. PubMed ID: 20581244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Imaging of NASH].
    Tanimoto A; Tomita K
    Nihon Rinsho; 2006 Jun; 64(6):1127-32. PubMed ID: 16768120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-alcoholic steatohepatitis in children.
    Nanda K
    Pediatr Transplant; 2004 Dec; 8(6):613-8. PubMed ID: 15598336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology and biopsy assessment of non-alcoholic fatty liver disease.
    Straub BK; Schirmacher P
    Dig Dis; 2010; 28(1):197-202. PubMed ID: 20460911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of quantitative 99mTc-phytate scintigraphy to diagnose early-stage non-alcoholic steatohepatitis.
    Kikuchi M; Tomita K; Nakahara T; Kitamura N; Teratani T; Irie R; Yokoyama H; Suzuki T; Yokoyama T; Taguchi T; Tanaka S; Noguchi M; Ohkura T; Hibi T
    Scand J Gastroenterol; 2009; 44(2):229-36. PubMed ID: 18819037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non-alcoholic liver disease (NASH)].
    Maier KP
    Praxis (Bern 1994); 2006 Aug; 95(34):1267-9. PubMed ID: 16956020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.